KRAS and adenocarcinoma: In a study of 210 CRC patients, investigators found that the KRAS mutation was associated with female gender, left localization, classical adenocarcinoma, vascular invasion, and the presence of positive lymph nodes and advanced disease stage in MSS cases [9].